Monocent Inc, Receives Authorization From COFEPRIS (Mexico) And INVIMA (Colombia), For Their US-Manufactured, CE Marked, Highly Accurate, Easy-To-Use, 15-Minute, COVID-19 Antigen Test
Published: Mar 17, 2021 CHATSWORTH, Calif., March 17, 2021 /PRNewswire/ -- Monocent Inc., (Monocent) is pleased to announce the COFEPRIS authorization of their SARS-CoV2 Antigen Rapid test System for detection of COVID-19 infection. The Monocent antigen test is a lateral flow test that provides results in just 15-minutes, without the use of any laboratory equipment. A collection of 3 rd party clinical evaluation studies from US, UK, Mexico, Columbia, India and China have shown the test to have 98% sensitivity and 100% specificity when compared to RT-PCR, making it ideal for large-scale...
Source: biospace.com